SCHEMBL14965682

SCHEMBL14965682

O=[N+]([O-])c1cn2c(n1)OCCN(Cc1ccccc1-c1ccccc1)CC2

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 7/20 0.44
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
DHODH Q02127 1/20 0.39
FAAH O00519 1/20 0.38
MGLL Q99685 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PDE10A Q9Y233 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
CASP1 P29466 1/20 0.35
CASP4 P49662 1/20 0.35
CASP5 P51878 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14965939 0.90 PDE9A (0.39) HTR7MEN1POLBKMT2ADHODH
SCHEMBL14965655 0.90 PDE4B (0.36) HTR7MEN1POLBKMT2ADHODH
SCHEMBL14971108 0.85 ALDH1A1 (0.44) FAAHMGLLKDM4EALDH1A1
SCHEMBL14965623 0.85 CYP2A13 (0.48) MEN1POLBKMT2AFAAHKDM4E
SCHEMBL14965809 0.85 ALDH1A1 (0.41) MEN1KMT2ADHODHKDM4EALDH1A1
SCHEMBL14965773 0.85 L3MBTL1 (0.46) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL14965775 0.83 L3MBTL1 (0.41) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL14971091 0.83 DRD2 (0.44) MEN1POLBKMT2AFAAHMGLL
SCHEMBL14965813 0.79 ALDH1A1 (0.53) MEN1POLBKMT2AKDM4EALDH1A1
SCHEMBL14965823 0.78 CLK2 (0.39) KDM4EALDH1A1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072903-A1 NITROIMIDAZOXADIAZOCINE COMPOUNDS ITHEMBA PHARMACEUTICALS (PROPRIETARY) LIMITED (ZA) 2013-05-23 WO disclosed